将特朗普总统针对跨性别健康与性别肯定照护的行政令置于背景中审视
本文评述特朗普政府自2025年1月以来颁布的反跨性别行政令与立法,通过梳理美国与欧洲历史上对跨性别身体的病理化与管控及医疗守门 legacy,批判行政令中的科学不准确之处,并概述相关立法(包括 United States v Skrmetti)的危害影响。
要点
- 特朗普政府自2025年1月起的反跨性别行政令与立法强制性别二元并限制青少年性别肯定照护获取。
- 作者通过历史病理化与医疗守门及照护标准演变来背景化这些攻击。
- 作者批判行政令中的科学不准确之处并概述相关立法(含 United States v Skrmetti)的有害影响。
核心结论
- 限制性别肯定照护与跨性别者生存权不仅加剧健康差异,也削弱医疗从业者与机构提供以患者为中心、循证照护的伦理责任。
- 作者认为不应屈从于试图伤害和抹除本已边缘化人群的政治努力。
研究设计与样本
- 本文为评述性文章,通过历史梳理与政策分析对行政令与立法进行背景化。
主要发现
- 特朗普政府自2025年1月以来的反跨性别行政令与立法已对卫生政策和照护获取产生广泛影响。
- 作者追溯了美国与欧洲对跨性别身体的病理化与管控历史及医疗守门的 legacy 与不断演变的照护标准。
- 作者批判了行政令中的科学不准确之处并概述了相关立法(包括 United States v Skrmetti)的有害影响。
临床怎么用
- 作者认为医疗从业者与机构不应屈从于试图伤害和抹除边缘化人群的政治努力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The antitransgender executive orders and legislation enacted by the Trump administration since January 2025 have focused on enforcing a gender binary and restricting access to gender-affirming care for youths. These actions have had sweeping effects on health policy and access to care in an already strained health care system. Here we contextualize these attacks on transgender health by exploring the historical pathologization and policing of transgender bodies in the United States and Europe while tracing the legacy of medical gatekeeping alongside evolving standards of care. We critique the scientific inaccuracies within the administration's executive orders while outlining the harmful impact of related and recent legislation, including United States v Skrmetti. Restrictions on gender-affirming care and the rights of transgender people to exist not only exacerbate health disparities but also undermine the ethical responsibility of medical practitioners and institutions to provide patient-centered, evidence-based care. We must not capitulate to political efforts that attempt to harm and erase an already marginalized population. (Am J Public Health. 2026;116(2):256-260. https://doi.org/10.2105/AJPH.2025.308265).
引用
- Nuruzzaman N, Hsiang E. Contextualizing President Trump's Executive Orders Targeting Transgender Health and Gender-Affirming Care. Am J Public Health. 2025. PMID: 41166663. doi:10.2105/AJPH.2025.308265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。